Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial
| Autor: | Ebert, Matthias P *, Meindl-Beinker, Nadja M, Gutting, Tobias, Maenz, Martin, Betge, Johannes, Schulte, Nadine, Zhan, Tianzuo, Weidner, Philip, Burgermeister, Elke, Hofheinz, Ralf, Vogel, Arndt, Angermeier, Stefan, Bolling, Claus, de Wit, Maike, Jakobs, Ralf, Karthaus, Meinolf, Stocker, Gertraud, Thuss-Patience, Peter, Leidig, Tobias, Gaiser, Timo, Kather, Jakob N, Haertel, Nicolai |
|---|---|
| Zdroj: | In The Lancet Healthy Longevity June 2022 3(6):e417-e427 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|